The EFMC is happy to announce the names of the 2020 Award winners.
For his leading contributions as a pioneer of GPCR drug discovery and structural biology, and his support of the medicinal chemistry and chemical biology community. His research led to over 450 publications, many of them achieving high international visibility. An excellent mentor and lecturer, Ad IJzerman played an active role in the International LACDR School on Medicinal Chemistry. He also chaired the medicinal chemistry division of the Royal Netherlands Chemical Society, organized many scientific symposia, and led several international research networks.
Dr Malin Lemurell (AstraZeneca, Sweden)
For her contribution to the discovery and development of several drug candidates and her leadership in medicinal chemistry. Her most recent contributions while leading a 60-strong medicinal chemistry group at AstraZeneca to deliver on pipeline projects in the Cardiovascular, Renal and Metabolism disease area across multiple modalities also includes harnessing innovation in the fields of RNA targeting with small molecules, RNA imaging with fluorescent nucleotide probes, machine learning applications in drug discovery projects and new modalities.
For his pioneering work integrating machine learning into medicinal chemistry, drug discovery and chemical biology. His contributions spread across the whole drug discovery process, and introduced visionary concepts for concrete applications of computational methods. These are now broadly adopted in drug discovery and recognized as robust foundations for transformative advancements in the field.
All 3 awards consist of a diploma, € 7.500 and an invitation to give a headline presentation at the EFMC International Symposium on Medicinal Chemistry.
The 2020 Awards will be presented at the XXVI EFMC "International Symposium on Medicinal Chemistry" (EFMC-ISMC 2020) to be held in Basel, Switzerland on September 6-10, 2020.